Header cover image

Banks Healthcare Sector

Results

2266

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2266 companies

GE HealthCare Technologies

Market Cap: US$34.4b

Engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally.

GEHC

US$73.66

7D

3.6%

1Y

-13.6%

Agilent Technologies

Market Cap: US$34.2b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

A

US$118.87

7D

4.3%

1Y

-15.0%

Humana

Market Cap: US$33.9b

Provides medical and specialty insurance products in the United States.

HUM

US$281.34

7D

9.8%

1Y

-21.2%

BeOne Medicines

Market Cap: US$33.8b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

ONC

US$309.69

7D

3.8%

1Y

62.2%

IQVIA Holdings

Market Cap: US$32.3b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

IQV

US$189.40

7D

5.8%

1Y

-21.4%

DexCom

Market Cap: US$31.4b

A medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally.

DXCM

US$79.96

7D

4.7%

1Y

10.5%

Mettler-Toledo International

Market Cap: US$27.3b

Manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.

MTD

US$1,313.64

7D

6.2%

1Y

-8.4%

BioNTech

Market Cap: US$27.1b

A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.

BNTX

US$112.70

7D

1.2%

1Y

29.2%

Insmed

Market Cap: US$26.0b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

INSM

US$127.75

7D

16.9%

1Y

72.3%

STERIS

Market Cap: US$24.3b

Provides infection prevention products and services worldwide.

STE

US$246.14

7D

4.2%

1Y

6.9%

Labcorp Holdings

Market Cap: US$22.6b

Provides laboratory services.

LH

US$271.25

7D

4.3%

1Y

20.8%

Insulet

Market Cap: US$21.7b

Develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally.

PODD

US$315.78

7D

4.0%

1Y

61.9%

Natera

Market Cap: US$21.6b

A diagnostics company, provides molecular testing services worldwide.

NTRA

US$158.44

7D

12.3%

1Y

29.6%

Sigma Healthcare

Market Cap: AU$33.0b

Operates as a pharmaceutical wholesaler, distributor, and pharmacy franchisor in Australia and internationally.

SIG

AU$2.86

7D

0%

1Y

n/a

Pro Medicus

Market Cap: AU$33.0b

A healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe.

PME

AU$315.69

7D

-1.3%

1Y

111.8%

Royalty Pharma

Market Cap: US$21.3b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

RPRX

US$36.50

7D

-1.4%

1Y

33.2%

Zimmer Biomet Holdings

Market Cap: US$20.4b

Operates as a medical technology company worldwide.

ZBH

US$102.12

7D

3.7%

1Y

-7.1%

Quest Diagnostics

Market Cap: US$20.0b

Provides diagnostic testing and services in the United States and internationally.

DGX

US$178.44

7D

2.4%

1Y

19.2%

Summit Therapeutics

Market Cap: US$20.0b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

SMMT

US$26.45

7D

-5.8%

1Y

122.8%

Biogen

Market Cap: US$19.8b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

BIIB

US$134.94

7D

5.6%

1Y

-33.1%

Teva Pharmaceutical Industries

Market Cap: US$19.7b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

TEVA

US$17.54

7D

7.7%

1Y

-4.3%

West Pharmaceutical Services

Market Cap: US$17.7b

Designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

WST

US$246.20

7D

2.4%

1Y

-15.9%

Waters

Market Cap: US$17.7b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

WAT

US$293.52

7D

5.6%

1Y

-13.8%

Incyte

Market Cap: US$16.8b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

INCY

US$86.16

7D

10.2%

1Y

39.7%

Smith & Nephew

Market Cap: UK£11.8b

Develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally.

SN.

UK£13.53

7D

0.6%

1Y

15.6%

Illumina

Market Cap: US$15.5b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

ILMN

US$100.09

7D

4.8%

1Y

-22.3%

Hologic

Market Cap: US$15.3b

Engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide.

HOLX

US$68.06

7D

0.2%

1Y

-15.5%

Tenet Healthcare

Market Cap: US$15.2b

Operates as a diversified healthcare services company in the United States.

THC

US$172.36

7D

5.5%

1Y

11.1%

Cooper Companies

Market Cap: US$14.8b

Develops, manufactures, and markets contact lens wearers.

COO

US$73.44

7D

6.1%

1Y

-20.2%

United Therapeutics

Market Cap: US$14.0b

A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

UTHR

US$312.06

7D

4.2%

1Y

-3.4%

ICON

Market Cap: US$13.7b

A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.

ICLR

US$175.36

7D

11.1%

1Y

-45.5%

Centene

Market Cap: US$13.3b

Operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States.

CNC

US$26.93

7D

6.6%

1Y

-65.7%

Medpace Holdings

Market Cap: US$13.1b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

MEDP

US$458.66

7D

7.0%

1Y

19.3%

Cochlear

Market Cap: AU$20.0b

Provides implantable hearing solutions for children and adults worldwide.

COH

AU$305.99

7D

-2.5%

1Y

-2.2%

Neurocrine Biosciences

Market Cap: US$13.1b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

NBIX

US$131.31

7D

4.5%

1Y

-11.1%

Fisher & Paykel Healthcare

Market Cap: NZ$21.8b

Designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally.

FPH

NZ$37.25

7D

0.7%

1Y

12.5%

Page 2 of 63